Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 31 | 2025 | 421 | 6.470 |
Why?
|
| Autistic Disorder | 25 | 2025 | 365 | 4.750 |
Why?
|
| Chromosomes, Human, Pair 16 | 12 | 2020 | 149 | 2.040 |
Why?
|
| Chromosome Disorders | 8 | 2020 | 315 | 1.340 |
Why?
|
| Child Development Disorders, Pervasive | 7 | 2015 | 82 | 1.230 |
Why?
|
| Parents | 12 | 2023 | 1060 | 1.160 |
Why?
|
| Developmental Disabilities | 8 | 2021 | 733 | 1.080 |
Why?
|
| Chromosome Deletion | 12 | 2020 | 664 | 0.950 |
Why?
|
| Vaccines | 3 | 2020 | 380 | 0.950 |
Why?
|
| Phenotype | 14 | 2020 | 4547 | 0.920 |
Why?
|
| DNA Copy Number Variations | 10 | 2021 | 1022 | 0.840 |
Why?
|
| Intellectual Disability | 6 | 2020 | 1076 | 0.780 |
Why?
|
| Chromosome Duplication | 6 | 2020 | 148 | 0.750 |
Why?
|
| Verbal Behavior | 1 | 2020 | 52 | 0.680 |
Why?
|
| Child | 44 | 2025 | 25739 | 0.660 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2021 | 894 | 0.640 |
Why?
|
| Paternal Behavior | 1 | 2019 | 12 | 0.640 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 23 | 0.630 |
Why?
|
| Maternal Behavior | 1 | 2019 | 71 | 0.600 |
Why?
|
| Heterozygote | 7 | 2021 | 718 | 0.600 |
Why?
|
| Hormones | 1 | 2019 | 195 | 0.590 |
Why?
|
| Sex Characteristics | 1 | 2019 | 336 | 0.540 |
Why?
|
| Intelligence | 5 | 2015 | 108 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2019 | 236 | 0.500 |
Why?
|
| Adolescent | 31 | 2025 | 20536 | 0.500 |
Why?
|
| Symbolism | 1 | 2015 | 4 | 0.500 |
Why?
|
| Patient Advocacy | 1 | 2015 | 62 | 0.480 |
Why?
|
| Vaccination | 3 | 2020 | 1011 | 0.450 |
Why?
|
| Anxiety | 4 | 2025 | 993 | 0.440 |
Why?
|
| Child, Preschool | 24 | 2020 | 14800 | 0.430 |
Why?
|
| Humans | 57 | 2025 | 133932 | 0.410 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 65 | 0.400 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2020 | 529 | 0.400 |
Why?
|
| Psychotropic Drugs | 2 | 2019 | 130 | 0.390 |
Why?
|
| Male | 40 | 2025 | 65882 | 0.380 |
Why?
|
| Social Behavior | 2 | 2015 | 230 | 0.370 |
Why?
|
| Referral and Consultation | 3 | 2022 | 571 | 0.360 |
Why?
|
| Sequence Deletion | 2 | 2019 | 537 | 0.350 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2020 | 22 | 0.340 |
Why?
|
| Female | 36 | 2025 | 71659 | 0.330 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 3476 | 0.330 |
Why?
|
| Speech Therapy | 1 | 2019 | 14 | 0.310 |
Why?
|
| Cognition | 5 | 2020 | 815 | 0.310 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 312 | 0.310 |
Why?
|
| Occupational Therapy | 1 | 2019 | 38 | 0.300 |
Why?
|
| Checklist | 1 | 2019 | 95 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 286 | 0.300 |
Why?
|
| Family Health | 2 | 2014 | 267 | 0.300 |
Why?
|
| Oxytocin | 2 | 2019 | 73 | 0.280 |
Why?
|
| Brain | 2 | 2019 | 3220 | 0.280 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 59 | 0.270 |
Why?
|
| Epilepsy | 2 | 2023 | 891 | 0.260 |
Why?
|
| Behavior Therapy | 1 | 2019 | 268 | 0.260 |
Why?
|
| Language | 2 | 2020 | 219 | 0.260 |
Why?
|
| Siblings | 3 | 2020 | 198 | 0.260 |
Why?
|
| Depression | 1 | 2025 | 1350 | 0.250 |
Why?
|
| Psychometrics | 4 | 2020 | 684 | 0.250 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 30 | 0.250 |
Why?
|
| Self-Injurious Behavior | 1 | 2016 | 66 | 0.240 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 38 | 0.240 |
Why?
|
| Proteins | 1 | 2020 | 1087 | 0.230 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 977 | 0.220 |
Why?
|
| Motion Perception | 1 | 2015 | 73 | 0.220 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 186 | 0.210 |
Why?
|
| Models, Neurological | 1 | 2015 | 223 | 0.210 |
Why?
|
| Adult | 15 | 2021 | 31946 | 0.200 |
Why?
|
| Sibling Relations | 1 | 2012 | 12 | 0.200 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 35 | 0.190 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 725 | 0.190 |
Why?
|
| Social Adjustment | 1 | 2012 | 80 | 0.190 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 63 | 0.190 |
Why?
|
| Carnitine | 1 | 2012 | 77 | 0.190 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 983 | 0.180 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 161 | 0.180 |
Why?
|
| Faculty | 1 | 2012 | 108 | 0.180 |
Why?
|
| Consumer Product Safety | 1 | 2010 | 32 | 0.180 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 121 | 0.170 |
Why?
|
| Syringomyelia | 1 | 2010 | 18 | 0.170 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 229 | 0.170 |
Why?
|
| Pediatrics | 1 | 2019 | 1217 | 0.160 |
Why?
|
| Speech | 1 | 2020 | 77 | 0.160 |
Why?
|
| Emotions | 1 | 2012 | 364 | 0.160 |
Why?
|
| Arginine Vasopressin | 1 | 2019 | 29 | 0.160 |
Why?
|
| Prolactin | 1 | 2019 | 115 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 71 | 0.150 |
Why?
|
| Folic Acid | 1 | 2010 | 298 | 0.150 |
Why?
|
| Young Adult | 7 | 2020 | 9887 | 0.150 |
Why?
|
| Intelligence Tests | 2 | 2015 | 63 | 0.140 |
Why?
|
| Fixation, Ocular | 1 | 2017 | 17 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 626 | 0.140 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 29 | 0.140 |
Why?
|
| Child Behavior | 1 | 2009 | 234 | 0.140 |
Why?
|
| Diseases in Twins | 1 | 2007 | 99 | 0.130 |
Why?
|
| Family | 1 | 2020 | 588 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 358 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 499 | 0.130 |
Why?
|
| Language Development Disorders | 2 | 2013 | 179 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2010 | 498 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2017 | 135 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1485 | 0.120 |
Why?
|
| Caregivers | 2 | 2022 | 586 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2019 | 314 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 896 | 0.120 |
Why?
|
| Aptitude | 1 | 2015 | 12 | 0.120 |
Why?
|
| Motor Skills | 1 | 2015 | 88 | 0.120 |
Why?
|
| Pedigree | 4 | 2017 | 1694 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 152 | 0.110 |
Why?
|
| Executive Function | 1 | 2015 | 125 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2022 | 789 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2016 | 371 | 0.110 |
Why?
|
| Communication | 2 | 2022 | 541 | 0.110 |
Why?
|
| Testosterone | 1 | 2019 | 596 | 0.110 |
Why?
|
| Mutation | 1 | 2017 | 6297 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 678 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 61 | 0.100 |
Why?
|
| Schizophrenia | 1 | 2016 | 332 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 357 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2015 | 3990 | 0.100 |
Why?
|
| Neurophysiology | 1 | 2012 | 20 | 0.090 |
Why?
|
| Infant | 5 | 2019 | 13161 | 0.090 |
Why?
|
| Asperger Syndrome | 3 | 2011 | 7 | 0.090 |
Why?
|
| Syndrome | 2 | 2020 | 1165 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1495 | 0.090 |
Why?
|
| Pediatricians | 1 | 2022 | 71 | 0.090 |
Why?
|
| Seizures | 1 | 2016 | 889 | 0.090 |
Why?
|
| Middle Aged | 5 | 2020 | 29394 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3640 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2012 | 198 | 0.080 |
Why?
|
| Texas | 2 | 2021 | 3689 | 0.080 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 33 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 192 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2013 | 850 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2023 | 13011 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2006 | 1066 | 0.080 |
Why?
|
| Neuroimaging | 1 | 2012 | 372 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 3171 | 0.080 |
Why?
|
| Age of Onset | 2 | 2015 | 635 | 0.080 |
Why?
|
| School Health Services | 1 | 2019 | 100 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2021 | 809 | 0.070 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 11 | 0.070 |
Why?
|
| Minority Groups | 1 | 2020 | 255 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 3072 | 0.070 |
Why?
|
| Genes, Essential | 1 | 2017 | 43 | 0.070 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2017 | 126 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 881 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2017 | 238 | 0.060 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 14 | 0.060 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 14 | 0.060 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 30 | 0.060 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 14 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 754 | 0.060 |
Why?
|
| Hepatitis B Vaccines | 1 | 2016 | 45 | 0.060 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2016 | 35 | 0.060 |
Why?
|
| Exons | 2 | 2013 | 832 | 0.060 |
Why?
|
| Consensus | 1 | 2019 | 739 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 920 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1094 | 0.060 |
Why?
|
| Canada | 1 | 2016 | 343 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 844 | 0.060 |
Why?
|
| North America | 1 | 2015 | 260 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17481 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2015 | 234 | 0.050 |
Why?
|
| Chromatin | 1 | 2017 | 609 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 239 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 11087 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 2977 | 0.050 |
Why?
|
| Internal-External Control | 1 | 2012 | 76 | 0.050 |
Why?
|
| Penetrance | 1 | 2012 | 111 | 0.050 |
Why?
|
| Personality Assessment | 1 | 2012 | 110 | 0.050 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Reference Values | 1 | 2012 | 742 | 0.040 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 22 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 43 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2021 | 102 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 505 | 0.040 |
Why?
|
| Socialization | 1 | 2007 | 17 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 2007 | 47 | 0.040 |
Why?
|
| Individuality | 1 | 2007 | 37 | 0.040 |
Why?
|
| United States | 2 | 2016 | 11683 | 0.040 |
Why?
|
| Animals | 1 | 2019 | 36398 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 7523 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 138 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 129 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2162 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1046 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 332 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 108 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2009 | 1337 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 85 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 163 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2016 | 131 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2654 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 431 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1667 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 123 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 347 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 2807 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 82 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 444 | 0.020 |
Why?
|
| Cerebellum | 1 | 2016 | 464 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2011 | 94 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1977 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1615 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1563 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3970 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5505 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5074 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1833 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1909 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5173 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 1711 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3849 | 0.010 |
Why?
|